Medicine and Health Sciences Commons^™

An Analysis Of Patient-Generated Health Data In Assisting Nurses And Physicians To Better Treat Patients With Hypertension, Diana Chaparadza

Applied Research Projects

Patient Generated Health Data (PGHD is not new but it has gained more attention these past years due to the advent of smart devices, remote monitoring devices and many applications on various smart devices. PGHD reflects medications and treatment, lifestyle choices, and health history. Unlike traditional medical visits, where clinicians collect and manage data within their offices, PGHD is collected by patients throughout the course of their day and provides an insight of how they are responding to treatments or lifestyle choices. Examples include blood glucose monitoring or blood pressure readings using home health equipment, exercise and diet tracking using …

An Assessment Of Utilization Of Prescription Anti-Hypertension Medications Via A Health Records Database, Ryan Payne

Applied Research Projects

Obesity is a growing problem in the United States, though not a new one. It was estimated that over 72 million U.S. adults alone have a diagnosis of obesity. Among all preventable premature deaths, obesity ranks as the second leading cause. Contemporary classifications define obesity as a body mass index (BMI) greater than or equal to 30. Several common comorbidities are widely present in obese populations, particularly hypertension, diabetes, and hyperlipidemia. Among these chronic disease states, hypertension has been identified as the most common and earliest identifiable. The purpose of this study was to make inferences on the prescribing of …

Group Iv Cytosolic Phospholipase A2Α Is Critical For The Development Of Angiotensin Ii-Induced Hypertension And Associated Pathogenesis, Nayaab Shehbaz Khan

Theses and Dissertations (ETD)

Angiotensin II (Ang II) activates cytosolic phospholipase A2α and releases arachidonic acid (AA) from tissue phospholipids. AA metabolites mediate or modulate one or more renocardiovascular effects of this peptide and have been implicated in hypertension. Since AA release is the rate limiting step in eicosanoid production, it is possible that cPLA2α might play a central role in the development of Ang II-induced hypertension. To test this hypothesis, we investigated the effect of Ang II infusion for 13 days by micro-osmotic pumps (700 ng/kg/min), on systolic blood pressure and associated pathophysiological changes in wild type (cPLA2α+/+) and cPLA2α-/- mice. Ang II …

The Development And Psychometric Testing Of A Hypertension Knowledge Instrument In A Vulnerable Population, Crescent Elayne Rowell

Theses and Dissertations (ETD)

The primary objective of the study was to assess the psychometric properties of a hypertension knowledge instrument in a vulnerable population. The secondary objective was to determine the association between hypertension knowledge and outcomes such as systolic and diastolic blood pressure and hemoglobin A1c.

A cross-sectional study was conducted using a convenience sample of 196 adults aged 18 years and older with hypertension. Item analysis was conducted to determine the reliability of the instrument. The factor structure was determined and confirmed using exploratory factor analysis and confirmatory factor analysis, respectively. Logistic regression analysis was used to determine the association between …

Effect Of Postmenopausal Hormone Replacement Therapy On Heart Rate Variability, Diane Todd Pace

Theses and Dissertations (ETD)

Minimal research has addressed effects of postmenopausal hormone replacement therapy (HRT) on heart rate variability (HRV), a measure of cardiovascular autonomic balance and a predictor of cardiac morbidity/mortality. Using an exploratory, pre-test/post-test design to describe HRV in postmenopausal women (PMW) before/after six weeks of HRT, twenty-four Black (n=15) and White (n=9) women, (mean age=55±4 years), were recruited from two primary care clinics (n=20) and one church population (n=4) in a large urban midsouth community. Cardiovascular risk factors for the sample included chronic illnesses of DM (n=8), HRT (n=11), both DM and HRT (n=4), smoking (n=9), non-exercise (n=11), and obesity quantified …